[Effects of erythropoietin on the cardiovascular system and the intradialytic hemodynamic behavior]. 1991

F Quarello, and G Martina, and G Beltrame, and R Boero, and G Forneris, and M Borca, and G M Iadarola, and E Stramignoni, and S Maffei, and G Piccoli
Istituto di Nefro-Urologia, Università degli Studi di Torino.

The aim of the study was to evaluate, before and after hemodialysis (HD), the effects of partial correction of anemia with erythropoietin on: cardiac index (CI), stroke index (SI), heart rate (HR), ventricular ejection index (EVI), mean arterial pressure (PAM) and systemic vascular resistance index (SVRI). Cardiac parameters were gathered by means of transthoracic bioimpedance (BoMed). Twelve patients (6 M, 6 F) aged 50.6 +/- 5 years, on HD for 92.8 +/- 15.9 months, were studied twice (basal, end of follow-up). Before rHuEPO therapy, 6 patients had a "pathologic" cardiac response to HD (defined as an increase of CI despite the reduction of pre-load). After rHuEPO, 5 out of 6 patients with a "pathologic" response reverted to a "normal" response, and 1 hypertensive patient from a "normal" to a "pathologic" response. The EVI, CI and SI of patients with "pathological" response significantly improved after rHuEPO as compared with pre rHuEPO values (EVI 1.36 +/- 0.14 vs 1.07 +/- 0.08, p = 0.023; CI 3.18 +/- 0.24 vs 1.78 +/- 0.27, p less than 0.01; SI 43 +/- 3.7 vs 24 +/- 3.8, p less than 0.01). In conclusion, partial correction of anemia with rHuEPO induces an improvement of myocardial performance, without significant hemodynamic adverse effects. Our results suggest also that anemia could play a significant role in the pathogenesis of myocardial disfunction in HD patients.

UI MeSH Term Description Entries
D007155 Immunologic Factors Biologically active substances whose activities affect or play a role in the functioning of the immune system. Biological Response Modifier,Biomodulator,Immune Factor,Immunological Factor,Immunomodulator,Immunomodulators,Biological Response Modifiers,Biomodulators,Factors, Immunologic,Immune Factors,Immunological Factors,Modifiers, Biological Response,Response Modifiers, Biological,Factor, Immune,Factor, Immunological,Factors, Immune,Factors, Immunological,Modifier, Biological Response,Response Modifier, Biological
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D002319 Cardiovascular System The HEART and the BLOOD VESSELS by which BLOOD is pumped and circulated through the body. Circulatory System,Cardiovascular Systems,Circulatory Systems
D004921 Erythropoietin Glycoprotein hormone, secreted chiefly by the KIDNEY in the adult and the LIVER in the FETUS, that acts on erythroid stem cells of the BONE MARROW to stimulate proliferation and differentiation.
D005260 Female Females
D006435 Renal Dialysis Therapy for the insufficient cleansing of the BLOOD by the kidneys based on dialysis and including hemodialysis, PERITONEAL DIALYSIS, and HEMODIAFILTRATION. Dialysis, Extracorporeal,Dialysis, Renal,Extracorporeal Dialysis,Hemodialysis,Dialyses, Extracorporeal,Dialyses, Renal,Extracorporeal Dialyses,Hemodialyses,Renal Dialyses
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic

Related Publications

F Quarello, and G Martina, and G Beltrame, and R Boero, and G Forneris, and M Borca, and G M Iadarola, and E Stramignoni, and S Maffei, and G Piccoli
April 1984, Japanese circulation journal,
F Quarello, and G Martina, and G Beltrame, and R Boero, and G Forneris, and M Borca, and G M Iadarola, and E Stramignoni, and S Maffei, and G Piccoli
March 2000, The Journal of the Association of Physicians of India,
F Quarello, and G Martina, and G Beltrame, and R Boero, and G Forneris, and M Borca, and G M Iadarola, and E Stramignoni, and S Maffei, and G Piccoli
May 1993, Journal of the American Society of Nephrology : JASN,
F Quarello, and G Martina, and G Beltrame, and R Boero, and G Forneris, and M Borca, and G M Iadarola, and E Stramignoni, and S Maffei, and G Piccoli
November 1978, Nihon Jinzo Gakkai shi,
F Quarello, and G Martina, and G Beltrame, and R Boero, and G Forneris, and M Borca, and G M Iadarola, and E Stramignoni, and S Maffei, and G Piccoli
January 1992, Clinical nephrology,
F Quarello, and G Martina, and G Beltrame, and R Boero, and G Forneris, and M Borca, and G M Iadarola, and E Stramignoni, and S Maffei, and G Piccoli
November 1995, Clinical nephrology,
F Quarello, and G Martina, and G Beltrame, and R Boero, and G Forneris, and M Borca, and G M Iadarola, and E Stramignoni, and S Maffei, and G Piccoli
January 2002, Contributions to nephrology,
F Quarello, and G Martina, and G Beltrame, and R Boero, and G Forneris, and M Borca, and G M Iadarola, and E Stramignoni, and S Maffei, and G Piccoli
May 2018, Biomedical engineering online,
F Quarello, and G Martina, and G Beltrame, and R Boero, and G Forneris, and M Borca, and G M Iadarola, and E Stramignoni, and S Maffei, and G Piccoli
September 2003, Cardiovascular research,
F Quarello, and G Martina, and G Beltrame, and R Boero, and G Forneris, and M Borca, and G M Iadarola, and E Stramignoni, and S Maffei, and G Piccoli
January 1999, Nephron,
Copied contents to your clipboard!